{
  "id": "PK_CYP1A2_INHIB_SUBSTRATE",
  "name": "CYP1A2 inhibition can increase exposure of CYP1A2 substrates",
  "domain": "PK",
  "severity": "major",
  "rule_class": "adjust_monitor",
  "tags": ["exposure_increase"],
  "actions": [
    "Avoid or use caution when combining CYP1A2 inhibitors with sensitive substrates.",
    "Monitor for excessive sedation, hypotension, or other toxicity depending on the substrate."
  ],
  "logic": {
    "enzyme": {
      "id": "CYP1A2",
      "A_role": "substrate",
      "B_role": "inhibitor"
    },
    "rationale": [
      "{B_name} inhibits CYP1A2, reducing metabolism of {A_name}.",
      "Reduced clearance may increase systemic exposure and adverse effects."
    ]
  },
  "explanation_template": "{B_name} inhibits CYP1A2 and {A_name} is a CYP1A2 substrate. This may increase {A_name} exposure and toxicity risk.",
  "references": [
    {
      "source": "Educational note",
      "citation": "CYP inhibition can increase exposure of CYP substrates; clinical impact varies by substrate sensitivity."
    }
  ]
}
